Stage III/IV lung cancer or metastatic lung cancer, which are unresectable and refractory to standard chemotherapy
Conditions
Interventions
Trans arterial chemo-embolization is repeated evcery 3 weeks in principle, and is conducted 3 times at minimum.
Sponsors
Kashiwa Kousei General Hospital, Department of Thoracic Surgery
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Mediasitnal and/or hilar tumors which are unresectablea and refbractory to standard chemotherapy. 2. Standard chemotherapy is not available because of elderly and complications. 3. Even having multiple metastatic lesions, long-term survival could be expected if the mediastinal or hilar tumors are shrunk. 4. Patients who agree for the risk and long-teerm forecast.
Exclusion criteria
Exclusion criteria: Patients with anaphylaxis for contrast medium.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| For non-resectable stage III/IV lung cancer or metastatic lung cancer, which are located at mediastinum or lung hilum and refractory to standard chemotherapy, or those tumors in elderly patients, trans arterial cheemo-embolization via bronchial artery is conducted each 3 weeks with 3 courses at minimum, of which efficacy and prognosis are investigated. | — |
Secondary
| Measure | Time frame |
|---|---|
| Accidental embolization at the non-target organs is investigated. | — |
Countries
Japan
Contacts
Public ContactHiroaki Nomori
Kashiwa Kousei General Hospital Department of Thoracic Surgery
Outcome results
None listed